These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 1828201
1. [Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasms]. Guidi L, Bartoloni C, Pellicanò P, Cappelli A, Cursi F, Pili R, Tricerri A, Patriarca F, Gambassi G. Clin Ter; 1991 Mar 31; 136(6):367-73. PubMed ID: 1828201 [Abstract] [Full Text] [Related]
2. [The thrombin-antithrombin III complex ELISA test in diagnosis of surgery-induced blood coagulation activation]. Kemen M, Sperling H, Mumme A, Zumtobel V. Infusionstherapie; 1991 Aug 31; 18(4):199-201. PubMed ID: 1937844 [Abstract] [Full Text] [Related]
3. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses. Topper MJ, Prasse KW, Morris MJ, Duncan A, Crowe NA. Am J Vet Res; 1996 Apr 31; 57(4):427-31. PubMed ID: 8712502 [Abstract] [Full Text] [Related]
4. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Pelzer H, Schwarz A, Heimburger N. Thromb Haemost; 1988 Feb 25; 59(1):101-6. PubMed ID: 3363526 [Abstract] [Full Text] [Related]
5. The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systems. Elgue G, Pasche B, Blombäck M, Olsson P. Thromb Haemost; 1990 Jun 28; 63(3):435-8. PubMed ID: 2205949 [Abstract] [Full Text] [Related]
6. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy. Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E. Anticancer Res; 1995 Jun 28; 15(6B):2731-7. PubMed ID: 8669855 [Abstract] [Full Text] [Related]
7. [The clinical applications of serum tumor markers in gastroenterology]. González Martínez M, Marín López E. Rev Gastroenterol Mex; 1993 Jun 28; 58(2):103-7. PubMed ID: 7747020 [Abstract] [Full Text] [Related]
8. [Detection of thrombin-antithrombin complexes in hypercoagulability conditions. Analysis of 182 cases]. Zuazu-Jausoro I, Borrell M, Urrutia T, Oliver A, Montserrat I, Mateo J, Ribera L, Fontcuberta J. Sangre (Barc); 1990 Oct 28; 35(5):375-9. PubMed ID: 2291147 [Abstract] [Full Text] [Related]
9. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation. Okajima K, Uchiba M, Murakami K, Okabe H, Takatsuki K. Am J Hematol; 1996 Mar 28; 51(3):186-91. PubMed ID: 8619398 [Abstract] [Full Text] [Related]
10. Determination of human thrombin-antithrombin III complex by enzyme immunoassay. Heimburger N, Pelzer H. Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Mar 28; 115(3):269-73. PubMed ID: 2465214 [Abstract] [Full Text] [Related]
11. Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'. Bartoloni C, Guidi L, Tricerri A, Patriarca F, Pili R, Cursi F, Canetta M, Cappelli A, Vangeli M, Salvati F. Oncology; 1992 Mar 28; 49(6):426-30. PubMed ID: 1465280 [Abstract] [Full Text] [Related]
12. Serum evaluation of soluble interferon-alpha/beta receptor and high-sensitivity C-reactive protein for diagnosis of the patients with gastrointestinal and hepatobiliary-pancreatic cancer. Miyake K, Imura S, Nishioka M, Batmunkh E, Sugimoto K, Ohmoto Y, Shimada M. Cytokine; 2010 Mar 28; 49(3):251-5. PubMed ID: 19879773 [Abstract] [Full Text] [Related]
13. [Importance of the determination of thrombin-antithrombin-III complexes in hypercoagulability states]. García Avello A, García Frade A, Sureda JL, Torrado MC. Sangre (Barc); 1991 Apr 28; 36(2):163. PubMed ID: 1866654 [No Abstract] [Full Text] [Related]
14. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation. Soncini M, Casazza F, Mattioli R, Bonfardeci C, Motta A, Cimminiello C. Minerva Med; 1997 Dec 28; 88(12):501-5. PubMed ID: 9540779 [Abstract] [Full Text] [Related]
15. [The clinical significance of thrombin-antithrombin III complex (TAT) and fibrinogen and fibrin degradation products (FDP) levels in ovarian cancer]. Sawaguchi K, Hojo T, Nozaki S, Yabushita H, Noguchi M, Nakanishi M. Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan 28; 44(1):73-8. PubMed ID: 1541865 [Abstract] [Full Text] [Related]
16. [Thrombin-antithrombin III complexes in plasma and subretinal fluid in patients with perforated retinal detachment]. Malukiewicz-Wiśniewska G, Kotschy M. Klin Oczna; 2000 Jan 28; 102(4):267-70. PubMed ID: 11291298 [Abstract] [Full Text] [Related]
19. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T, von Lessen A, Welters I, Wagner RM, Ruwoldt R, Boldt J, Hempelmann G. Infusionsther Transfusionsmed; 1994 Aug 28; 21(4):244-50. PubMed ID: 7950289 [Abstract] [Full Text] [Related]
20. [Molecular marker for detecting hypercoagulable state]. Magari Y, Mizunaga S, Ito M, Shibata T, Ito H. Rinsho Byori; 1994 Jan 28; 42(1):22-33. PubMed ID: 8107279 [Abstract] [Full Text] [Related] Page: [Next] [New Search]